These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7919151

  • 1. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
    Ricardo SD, Bertram JF, Ryan GB.
    J Am Soc Nephrol; 1994 Jun; 4(12):1974-86. PubMed ID: 7919151
    [Abstract] [Full Text] [Related]

  • 2. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD, Bertram JF, Ryan GB.
    Exp Nephrol; 1995 Jun; 3(5):270-9. PubMed ID: 7583048
    [Abstract] [Full Text] [Related]

  • 3. Reactive oxygen species in puromycin aminonucleoside nephrosis: in vitro studies.
    Ricardo SD, Bertram JF, Ryan GB.
    Kidney Int; 1994 Apr; 45(4):1057-69. PubMed ID: 8007575
    [Abstract] [Full Text] [Related]

  • 4. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
    Kojima K, Matsui K, Nagase M.
    Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
    [Abstract] [Full Text] [Related]

  • 5. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
    Higuchi A.
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):767-75. PubMed ID: 2273594
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
    Magil A.
    J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623
    [Abstract] [Full Text] [Related]

  • 7. Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy.
    Gwinner W, Landmesser U, Brandes RP, Kubat B, Plasger J, Eberhard O, Koch KM, Olbricht CJ.
    J Am Soc Nephrol; 1997 Nov; 8(11):1722-31. PubMed ID: 9355075
    [Abstract] [Full Text] [Related]

  • 8. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
    Olson JL, Rennke HG, Venkatachalam MA.
    Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
    [Abstract] [Full Text] [Related]

  • 9. A role for oxygen free radicals in aminonucleoside nephrosis.
    Diamond JR, Bonventre JV, Karnovsky MJ.
    Kidney Int; 1986 Feb; 29(2):478-83. PubMed ID: 3702206
    [Abstract] [Full Text] [Related]

  • 10. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
    Wang JS, Yang AH, Chen SM, Young TK, Chiang H, Liu HC.
    Nephron; 1993 Feb; 65(3):418-25. PubMed ID: 8289993
    [Abstract] [Full Text] [Related]

  • 11. Effects of saikosaponin-d on aminonucleoside nephrosis in rats.
    Abe H, Orita M, Konishi H, Arichi S, Odashima S.
    Eur J Pharmacol; 1986 Jan 21; 120(2):171-8. PubMed ID: 3948917
    [Abstract] [Full Text] [Related]

  • 12. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats.
    Yamanaka M, Tamura Y, Kuribayashi-Okuma E, Uchida S, Shibata S.
    Am J Physiol Renal Physiol; 2023 Feb 01; 324(2):F168-F178. PubMed ID: 36454699
    [Abstract] [Full Text] [Related]

  • 13. Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
    Inokuchi S, Shirato I, Kobayashi N, Koide H, Tomino Y, Sakai T.
    Kidney Int; 1996 Oct 01; 50(4):1278-87. PubMed ID: 8887289
    [Abstract] [Full Text] [Related]

  • 14. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
    Nakamura T, Kimura K, Ebihara I, Takahashi T, Tomino Y, Aikawa M, Yazaki Y, Nagai R, Koide H.
    Clin Sci (Lond); 1995 Jul 01; 89(1):45-52. PubMed ID: 7671567
    [Abstract] [Full Text] [Related]

  • 15. Combined light and electron-microscope morphometric studies of acute puromycin aminonucleoside nephropathy in rats.
    Pinto JA, Brewer DB.
    J Pathol; 1975 Jul 01; 116(3):149-64. PubMed ID: 1104792
    [Abstract] [Full Text] [Related]

  • 16. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
    Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T.
    Clin Exp Nephrol; 2009 Oct 01; 13(5):438-446. PubMed ID: 19452240
    [Abstract] [Full Text] [Related]

  • 17. In vitro effects of puromycin aminonucleoside on the ultrastructure of rat glomerular podocytes.
    Bertram JF, Messina A, Ryan GB.
    Cell Tissue Res; 1990 May 01; 260(3):555-63. PubMed ID: 2372813
    [Abstract] [Full Text] [Related]

  • 18. A morphometric, biochemical and histochemical comparison of puromycin aminonucleoside and hyperalbuminaemic induced proteinurias in the female Wistar rat.
    Lawrence GM, Brewer DB.
    J Pathol; 1983 Feb 01; 139(2):115-40. PubMed ID: 6827398
    [Abstract] [Full Text] [Related]

  • 19. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
    Lee YK, Kwon T, Kim DJ, Huh W, Kim YG, Oh HY, Kawachi H.
    Nephrol Dial Transplant; 2004 Dec 01; 19(12):2981-6. PubMed ID: 15385636
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries.
    Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I.
    Kidney Int; 1991 Aug 01; 40(2):291-301. PubMed ID: 1942778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.